期刊文献+

替罗非班对老年急性ST段抬高心肌梗死患者心肌再灌注及左心功能的影响 被引量:1

Influence of tirofiban on myocardial reperfusion and left ventricular function of elderly patients with acute ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的探讨替罗非班对老年急性ST段抬高心肌梗死患者的心肌再灌注与左心功能的影响。方法 112例老年急性ST段抬高心肌梗死患者按照随机数字法分为对照组和研究组,均给予经皮冠状动脉介入治疗,对照组术中给予常规治疗,研究组术中给予替罗非班治疗,观察其对心肌再灌注与左心功能的影响。结果研究组心肌再灌注发生率明显高于对照组,两组比较差异有统计学意义(P<0.05)。研究组的左室射血分数(LVEF)明显高于对照组,差异有统计学意义(P<0.05)。结论老年急性ST段抬高心肌梗死患者在经皮冠状动脉介入治疗过程中应用替罗非班是可行的,改善患者的心肌再灌注和心功能,值得临床应用。 Objective To investigate the influence of tirofiban on myocardial reperfusion and left ventricular function of elderly patients with acute ST-segment elevation myocardial infarction. Methods A total of 112 elderly patients with acute ST-segment elevation myocardial infarction were randomly divided into control group and study group according to Random number method. After given percutaneous coronary intervention, patients in the control group received conventional therapy, while patients in the study group were given tirofiban treatment. The influence of tirofiban on myocardial reperfusion and left ventricular function was observed. Results The incidence of myocardial reperfusion in the study group was significantly higher than that of the control group. Difference between the two groups was statistically significant(P〈0.05). Left ventricular ejection fraction(LVEF) values of the study group was significantly higher than that of the control group, and the difference was statistically significant(P〈0.05). Conclusion Tirofiban applied in elderly patients of acute ST-segment elevation myocardial infarction patients with percutaneous coronary intervention is feasible, and it can improve myocardial reperfusion and heart function. It is worthy of clinical application.
出处 《中国实用医药》 2014年第27期13-14,共2页 China Practical Medicine
关键词 老年 急性ST段抬高心肌梗死 替罗非班 心肌再灌注 左心功能 Elderly patients Acute ST-segment elevation myocardial infarction Tirofiban Myocardial reperfusion Left ventricular function
  • 相关文献

参考文献5

二级参考文献40

  • 1沈杰,张奇,张瑞岩,张建盛,胡健,杨震坤,张宪,郑爱芳,沈卫峰.替罗非班在急性冠脉综合征患者中应用的安全性和出血相关因素分析[J].临床内科杂志,2007,24(1):14-17. 被引量:17
  • 2韩晓宁,丁文惠,洪涛,史力斌,褚松筠.盐酸替罗非班对心肌梗死患者微循环再灌注的影响[J].中华老年心脑血管病杂志,2007,9(6):373-375. 被引量:5
  • 3The RESTORE investigators. Effects of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997,96(5): 1445-1453.
  • 4Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J, 2005,26 (8) :804-847.
  • 5Servoss SJ, Wan Y, Snapinn SM, et al. Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. Am J Cardiol, 2004,93 (7) :843-847.
  • 6Valgimigli M, Percoco G, Barbieri D, et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. J Am Coll Cardiol, 2004,44( 1 ) :14-19.
  • 7Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 2006,114 ( 8 ) :774-782.
  • 8Limbruno U,Micheli A,De Carlo M,et al.Mechanical preventionof distal embolization during primary angioplasty:safety,feasi-bility,and impact on myocardial reperfusion[J].Circulation,2003,108(2):171-176.
  • 9EPIC Investigators.Use of a monoclonal antibody directed againstthe platelet glycoproteinⅡb/Ⅲa receptor in high risk coronaryangioplasty.The EPIC Investigation[J].N Engl J Med,1994,330(14):956-961.
  • 10The RESTORE Investigators.Effects of platelet glycoprotein Ilb/Illablockade with tirofiban on adverse cardiaC events in patientswithunstable angina or acute myocardial infarction undergoingcoronary angioplasty[J].Circulation,1997,96(5):1445-1453.

共引文献33

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部